WordNet

(mechanics) the equal and opposite force that is produced when any force is applied to a body; "every action has an equal and opposite reaction"
a response that reveals a persons feelings or attitude; "he was pleased by the audiences reaction to his performance"; "John feared his mothers reaction when she saw the broken lamp"
a bodily process occurring due to the effect of some antecedent stimulus or agent; "a bad reaction to the medicine"; "his responses have slowed with age" (同)response
doing something in opposition to another way of doing it that you dont like; "his style of painting was a reaction against cubism"
an idea evoked by some experience; "his reaction to the news was to start planning what to do"
extreme conservatism in political or social matters; "the forces of reaction carried the election"
apply (usually a liquid) to a surface; "dab the wall with paint" (同)swab, swob
a small quantity of something moist or liquid; "a dab of paint"; "a splatter of mud"; "just a splash of whiskey" (同)splash, splatter
hit lightly; "pat him on the shoulder" (同)pat
the 4th letter of the Roman alphabet (同)d

PrepTutorEJDIC

{名}(…に対する)『反応』《+『to』+『名』》 / 〈U〉(…に対する)(政治的・社会的な)『反動』,逆コース《+『against』+『名』》 / 〈U〉〈C〉化学反応,化学変化 / 〈U〉〈C〉(物理学で)反作用
(柔らかい物・湿った物などで)…'を'軽くたたく,軽く押える《+『名』+『with』+『名』》 / (…に)…'を'軽くなすりつける《+『名』+『on』(『onto, over』)+『名』》 / (…を)軽くたたく《+『at』+『名』》 / (…を)軽くたたくこと,軽く塗りつけること《+『at』+『名』》 / 《話》《a~》(…の)一塗り;少量(の…)《+『of』+『名』》
マコガレイ(カレイの一種)
(…の)名人,達人《+『at』+『名』》
deuteriumの化学記号

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 薬物アレルギー：分類および臨床的特徴 drug allergy classification and clinical features
2. 分子標的剤およびその他の生物製剤を用いた癌治療による皮膚合併症 cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy
3. 全身化学療法に対する輸注反応 infusion reactions to systemic chemotherapy
4. 癌治療に用いられる治療用モノクローナル抗体に対する輸注反応 infusion reactions to therapeutic monoclonal antibodies used for cancer therapy
5. 造影剤に対する即時型過敏反応：再発反応の予防 immediate hypersensitivity reactions to radiocontrast media prevention of recurrent reactions

English Journal

Thermal and photochemical reactivity of manganese tricarbonyl and tetracarbonyl complexes with a bulky diazabutadiene ligand.

Yempally V1, Kyran SJ, Raju RK, Fan WY, Brothers EN, Darensbourg DJ, Bengali AA.Author information 1Department of Chemistry, Texas A&M University at Qatar , Doha, Qatar.AbstractThe manganese tricarbonyl complex fac-Mn(Br)(CO)3((i)Pr2Ph-DAB) (1) [(i)Pr2Ph-DAB = (N,N'-bis(2,6-di-isopropylphenyl)-1,4-diaza-1,3-butadiene)] was synthesized from the reaction of Mn(CO)5Br with the sterically encumbered DAB ligand. Compound 1 exhibits rapid CO release under low power visible light irradiation (560 nm) suggesting its possible use as a photoCORM. The reaction of compound 1 with TlPF6 in the dark afforded the manganese(I) tetracarbonyl complex, [Mn(CO)4((i)Pr2Ph-DAB)][PF6] (2). While 2 is comparatively more stable than 1 in light, it demonstrates high thermal reactivity such that dissolution in CH3CN or THF at room temperature results in rapid CO loss and formation of the respective solvate complexes. This unusual reactivity is due to the large steric profile of the DAB ligand which results in a weak Mn-CO binding interaction.
Inorganic chemistry.Inorg Chem.2014 Apr 21;53(8):4081-8. doi: 10.1021/ic500025k. Epub 2014 Apr 1.
The manganese tricarbonyl complex fac-Mn(Br)(CO)3((i)Pr2Ph-DAB) (1) [(i)Pr2Ph-DAB = (N,N'-bis(2,6-di-isopropylphenyl)-1,4-diaza-1,3-butadiene)] was synthesized from the reaction of Mn(CO)5Br with the sterically encumbered DAB ligand. Compound 1 exhibits rapid CO release under low power visible light
PMID 24689898

Organometallic-Route Synthesis, Controllable Growth, Mechanism Investigation, and Surface Feature of PbSe Nanostructures with Tunable Shapes.

Shao G1, Chen G, Yang W, Ding T, Zuo J, Yang Q.Author information 1Hefei National Laboratory of Physical Sciences at the Microscale, ‡Department of Chemistry, and §Laboratory of Nanomaterials for Energy Conversion, University of Science and Technology of China (USTC) , Hefei 230026, Anhui, People's Republic of China.AbstractLead selenide (PbSe) nanostructures with well-defined star-shaped morphology are successfully fabricated via a facile organometallic synthetic route from the reaction of tetraphenyl lead (Ph4Pb) with triphenylphosphine selenide (Ph3PSe) in dibenzylamine (DBA) with the assistance of oleic acid (OA) and oleylamine (OAm) at 220 °C for 30 min. The structure and shape of the nanocrystals are investigated by techniques of XRD, SEM, TEM, HRTEM, SAED, and EDX, and it is interesting that the obtained PbSe nanostars present Pb-rich features, although the PbSe nanostars are still in typical rock salt phase. Experimental investigations and ATR-FTIR studies demonstrate that the media of DBA, OA, and OAm with an order OA > DAB > OAm play important roles in the growth of the PbSe nanostars with well-defined shapes because the media not only serve as solvents but capping materials. The synergetic effects of the media are also favorable for the growth of PbSe nanocrystals with the well-defined star-shaped morphologies in the current reaction system. Meanwhile, varied PbSe nanostructures with cubic, side-cut cubic, and octahedral shapes can be fabricated by regulating the relevant reaction conditions, and all of these nanostructures prepared in the procedures demonstrate Pb-rich features due to the selective capping effects of the media to the exposed Pb(II) ions. It is confirmed that the specific shape and geometry of the nanostructures can be tuned by controlling the exposed crystal surfaces and/or the corresponding compositions via the variation of reaction conditions in the media.
Langmuir : the ACS journal of surfaces and colloids.Langmuir.2014 Mar 18;30(10):2863-72. doi: 10.1021/la4042869. Epub 2014 Mar 7.
Lead selenide (PbSe) nanostructures with well-defined star-shaped morphology are successfully fabricated via a facile organometallic synthetic route from the reaction of tetraphenyl lead (Ph4Pb) with triphenylphosphine selenide (Ph3PSe) in dibenzylamine (DBA) with the assistance of oleic acid (OA) a
PMID 24559144

TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.

Ma Y1, Xin Y1, Li R1, Wang Z2, Yue Q1, Xiao F1, Hao X3.Author information 1Department of Clinical Laboratory, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.2Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.3Department of Clinical Laboratory, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Electronic address: haoxkg@fmmu.edu.cn.AbstractTFDP3 has been previously identified as an inhibitor of E2F molecules. It has been shown to suppress E2F1-induced apoptosis dependent P53 and to play a potential role in carcinogenesis. However, whether it indeed helps cancer cells tolerate apoptosis stress in cancer tissues remains unknown. TFDP3 expression was assessed by RT-PCR, in situ hybridization and immunohistochemistry in normal human tissues, cancer tissues and prostate cancer tissues. The association between TFDP3 and E2F1 in prostate cancer development was analyzed in various stages. Apoptosis was evaluated with annexin-V and propidium iodide staining and flow-cytometry. The results show that, in 96 samples of normal human tissues, TFDP3 could be detected in the cerebrum, esophagus, stomach, small intestine, bronchus, breast, ovary, uterus, and skin, but seldom in the lung, muscles, prostate, and liver. In addition, TFDP3 was highly expressed in numerous cancer tissues, such as brain-keratinous, lung squamous cell carcinoma, testicular seminoma, cervical carcinoma, skin squamous cell carcinoma, gastric adenocarcinoma, liver cancer, and prostate cancer. Moreover, TFDP3 was positive in 23 (62.2%) of 37 prostate cancer samples regardless of stage. Furthermore, immunohistochemistry results show that TFDP3 was always expressed in coordination with E2F1 at equivalent expression levels in prostate cancer tissues, and was highly expressed particularly in samples of high stage. When E2F1 was extrogenously expressed in LNCap cells, TFDP3 could be induced, and the apoptosis induced by E2F1 was significantly decreased. It was demonstrated that TFDP3 was a broadly expressed protein corresponding to E2F1 in human tissues, and suggested that TFDP3 is involved in prostate cancer cell survival by suppressing apoptosis induced by E2F1.
Gene.Gene.2014 Mar 10;537(2):253-9. doi: 10.1016/j.gene.2013.12.051. Epub 2014 Jan 7.
TFDP3 has been previously identified as an inhibitor of E2F molecules. It has been shown to suppress E2F1-induced apoptosis dependent P53 and to play a potential role in carcinogenesis. However, whether it indeed helps cancer cells tolerate apoptosis stress in cancer tissues remains unknown. TFDP3 e
PMID 24406621

Japanese Journal

Development of an Enzyme-Linked Immunosorbent Assay System to Determine the Presence of Antibodies Specific for Taxane Structures

Muto Satoshi,Kouyama Yuichi,Yokoyama Yuusaku [他],Okuno Hiroaki,Ishii Toshihiro,Masaka Toru,Matsuzawa Yasuo,Kawashima Tatsuo,Shirai Koji
Biological and Pharmaceutical Bulletin 34(4), 562-566, 2011
… Although the cause of the HSR is commonly thought to be a non-immunological direct effect of the diluent which is used to dissolve paclitaxel, some reports suggest the possibility of the presence of an immunological reaction to the common taxane structure. … To prepare an enzyme-linked immunosorbent assay (ELISA) plate for determining taxanes, 10-deacetylbaccatin III (DAB) was first succinylated by use of dimethylaminopyridine and succinic anhydride in dried pyridine. …
NAID 130000657848

Versatility of Bidentate Aniline Derivatives as Ligands for Rhenium(V) and Technetium(V)

GERBER T. I. A.,MAYER P.
Journal of nuclear and radiochemical sciences 6(3), 165-168, 2005-12-28
… The reaction of (n-Bu4N) [MOCl4] (M=Re, Tc) with 1, 2-diaminobenzene (H2dab) and 2, 3-diaminopyridine (H2dap) gave the products (Bu4N) [MO (dab) 2] (1) and [MO (dapH) 2]Cl (2) respectively. …
NAID 10025719305